Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence and bioequivalence study of generic levodopa/benserazide versus Madopar in Parkinson's disease
2012-001245-40Phase 4Completed
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levodopa + benserazide, levodopa and benserazide in Parkinson's disease (PD) (2 arms). Primary endpoints: Change in UPDRS part III total motor score and Total area under the concentration-time curve (AUC). Started May 2013; status: completed.
02
Drugs
levodopa + benserazidelevodopabenserazide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2012-001245-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001245-40.